ID   SCCIC1Met
AC   CVCL_VJ58
SY   SCCIC1MET; SCC IC1MET; IC1MET
DR   CancerTools; 153676
DR   GEO; GSM2611458
DR   GEO; GSM2611459
DR   GEO; GSM2611460
DR   Wikidata; Q98129377
DR   Ximbio; 153676
RX   PubMed=29755650;
RX   PubMed=30202019;
RX   PubMed=31336867;
CC   Omics: Deep exome analysis.
CC   Omics: Transcriptome analysis by microarray.
CC   Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000029.
ST   Source(s): PubMed=31336867
ST   Amelogenin: X,Y
ST   CSF1PO: 12,14
ST   D13S317: 9,13
ST   D16S539: 9,13
ST   D18S51: 15,17
ST   D19S433: 15,16.2
ST   D21S11: 29,30
ST   D2S1338: 19,25
ST   D3S1358: 14,17
ST   D5S818: 11,13
ST   D7S820: 8,11
ST   D8S1179: 13
ST   FGA: 21,24
ST   TH01: 9.3
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C4819; Skin squamous cell carcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
OI   CVCL_G300 ! SCCIC1
SX   Male
AG   77Y
CA   Cancer cell line
DT   Created: 07-09-18; Last updated: 10-09-24; Version: 7
//
RX   PubMed=29755650; DOI=10.18632/oncotarget.24750; PMCID=PMC5945540;
RA   McHugh A., Fernandes K., South A.P., Mellerio J.E., Salas-Alanis J.C.,
RA   Proby C.M., Leigh I.M., Saville M.K.;
RT   "Preclinical comparison of proteasome and ubiquitin E1 enzyme
RT   inhibitors in cutaneous squamous cell carcinoma: the identification of
RT   mechanisms of differential sensitivity.";
RL   Oncotarget 9:20265-20281(2018).
//
RX   PubMed=30202019; DOI=10.1038/s41467-018-06027-1; PMCID=PMC6131170;
RA   Inman G.J., Wang J., Nagano A., Alexandrov L.B., Purdie K.J.,
RA   Taylor R.G., Sherwood V., Thomson J., Hogan S., Spender L.C.,
RA   South A.P., Stratton M.R., Chelala C., Harwood C.A., Proby C.M.,
RA   Leigh I.M.;
RT   "The genomic landscape of cutaneous SCC reveals drivers and a novel
RT   azathioprine associated mutational signature.";
RL   Nat. Commun. 9:3667.1-3667.14(2018).
//
RX   PubMed=31336867; DOI=10.3390/ijms20143428; PMCID=PMC6678499;
RA   Hassan S., Purdie K.J., Wang J., Harwood C.A., Proby C.M.,
RA   Pourreyron C., Mladkova N., Nagano A., Dhayade S., Athineos D.,
RA   Caley M., Mannella V., Blyth K., Inman G.J., Leigh I.M.;
RT   "A Unique panel of patient-derived cutaneous squamous cell carcinoma
RT   cell lines provides a preclinical pathway for therapeutic testing.";
RL   Int. J. Mol. Sci. 20:3428.1-3428.26(2019).
//